The pharmaceutical sector has been attracting strong investor interest. Pharma and healthcare funds have delivered an average ...

In the international business, the US Generics division grew by 5%, contributing ₹467 crore, with eight new product launches in the US market.

The total income of Mankind Pharma, which includes other income, surged 15.09 per cent to Rs 3,185.94 crore in the September ...

John Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism ...

Nifty moved in a tight range of 82 points, and ended slightly below the psychologically crucial level of 15,700. NEW DELHI: The Nifty Pharma index traded around 10:49AM(IST)on Tuesday in a weak market ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Renew X Pharma has launched a new website, offering a user-friendly platform for individuals seeking reliable wellness ...

Leading pharmaceutical companies, such as Teva and Siemens Healthineers, reported significant profit growth, leading to ...

This year’s scholar is Lucy Chadwick, who is undertaking the Executive MBA. Currently Global Partnerships Manager at Forte Healthcare, an Irish-owned animal health SME, she initially qualified and ...

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...

Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax through profitability; proforma cash approaching $800 mil ...

To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...